Plunkett Research Online: Enochian BioSciences

ENOCHIAN BIOSCIENCES (ENOB:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

An immunotherapy company.....

Enochian BioSciences
Ticker: ENOB
Exchange: NAS
Parent Company:
Year Established:
Fiscal Year Ends in

Address: 2080 Century Park East
Suite 906
Century City Medical Plaza
Los Angeles, CA 90067-2012 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
Contacts Description

Luisa Puche CFO
Rene Sindlev Chairman of the Board/Director
See More
An immunotherapy company.....See More See More

Auditor: Sadler, Gibb & Associates, LLC
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016 2015
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: